Your session is about to expire
← Back to Search
Genetic Counseling Sequence for Heart Disease (RESEQUENCEGC Trial)
N/A
Waitlist Available
Led By Cynthia James
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Clinical diagnosis or suspected clinical diagnosis of a potentially inherited cardiovascular disease including hypertrophic, dilated, or arrhythmogenic cardiomyopathy, ventricular or atrial arrhythmias, or an ECG-pattern suspicious for an inherited cardiovascular disease including catecholaminergic polymorphic ventricular tachycardia, long QT syndrome, or Brugada syndrome, or a diagnosed or suspected lipid disorder or early-onset coronary artery disease
Documented pathogenic or likely pathogenic variant in a gene associated with a hereditary cardiomyopathy, arrhythmia syndrome, or lipid disease in a family member
Must not have
Previous genetic testing that definitively identified the genetic cause of the patient's condition
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months post results disclosure
Awards & highlights
No Placebo-Only Group
Summary
This trialwill test whether tailored pre-test genetic counseling followed by post-test counseling increases efficiency and improves outcomes for those seeking genetic testing for medical management.
Who is the study for?
Adults over 18 with suspected or diagnosed inherited heart conditions, including various cardiomyopathies, arrhythmias, lipid disorders, or early-onset coronary artery disease. They must be scheduled for genetic counseling at the Johns Hopkins Center and have not had previous genetic counseling/testing for their condition there.
What is being tested?
The trial is testing a new approach to cardiovascular genetic counseling by providing pre-test education via video and post-test counseling sessions. It compares usual care with two other methods: one where a call with a counselor before testing is optional and another where it's required.
What are the potential side effects?
This study does not involve medication; therefore, traditional side effects are not applicable. However, participants may experience psychological impacts from learning about their genetic risks.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I may have a genetic heart condition or early heart disease.
Select...
A family member has a genetic heart or lipid condition.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
My condition's genetic cause has been identified through testing.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6-months post results disclosure
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months post results disclosure
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Anxiety as measured on the Hospital Anxiety and Depression Scale (HADS)
Change in empowerment as measured on the Genetic Counseling Outcomes Scale (GCOS)
Efficiency as assessed by minutes of counseling time
+1 moreSecondary study objectives
Change in engagement as assessed by Patient Activation Measure
Informed Choice as assessed by Multidimensional Model of informed Choice pilot scales
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: FlippedExperimental Treatment2 Interventions
Pre-test genetics education by educational video with a REQUIRED call with a genetic counselor to address questions. Pre-test appointment available by request. Post-test genetic counseling appointment.
Group II: EfficiencyExperimental Treatment2 Interventions
Pre-test genetics education by educational video with an OPTIONAL call with a genetic counselor to address questions. Pre-test appointment available by request. Post-test genetic counseling appointment.
Group III: Standard of careActive Control1 Intervention
Pre-test genetic counseling appointment with results returned by phone or EHR. Post-test appointment available upon request.
Find a Location
Who is running the clinical trial?
National Human Genome Research Institute (NHGRI)NIH
270 Previous Clinical Trials
293,559 Total Patients Enrolled
4 Trials studying Genetic Counseling
1,195 Patients Enrolled for Genetic Counseling
Johns Hopkins UniversityLead Sponsor
2,339 Previous Clinical Trials
14,881,163 Total Patients Enrolled
Cynthia JamesPrincipal InvestigatorJohns Hopkins University
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You do not need a specific genetic test.My condition's genetic cause has been identified through testing.I am referred for genetic testing due to family heart disease history.You need a specific test for heart-related issues.I may have a genetic heart condition or early heart disease.I am an adult scheduled for genetic counseling at Johns Hopkins for inherited heart diseases.My genetic counseling won't involve genetic testing.A family member has a genetic heart or lipid condition.
Research Study Groups:
This trial has the following groups:- Group 1: Efficiency
- Group 2: Standard of care
- Group 3: Flipped
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.